Not applicableActive Not RecruitingNCT07123350
What this trial is testing
Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
Who this might be right for
Inflammatory Bowel Disease (IBD)Crohn&Amp;#39;s Disease (CD)Ulcerative Colitis (UC)
Vanderbilt University Medical Center 120